[Phase II study of etoposide (NK 171) in trophoblastic disease. Study Group on Etoposide (NK 171) for Trophoblastic Disease].
D004341:Drug Evaluation; D005047:Etoposide / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D011247:Pregnancy; D014328:Trophoblastic Neoplasms / Q000188:drug therapy*; D014594:Uterine Neoplasms / Q000188:drug therapy*
D005047:Etoposide